A single nucleotide polymorphism in the human PIGK gene associates with low PIGK expression in colorectal cancer patients

Abstract

Abstract. Colorectal cancer (CRC) represents one of the highest incidences of cancers worldwide. Phosphatidylinositol glycan, class K (PIGK), is a crucial member of the glycosylphosphatidylinositol transamidase (GPIT) protein complex that attaches a diverse group of macromolecules to the plasma membrane of eukaryotes. However, the precise role of PIGK in tumorigenesis remains largely unknown. Recently, we reported low expression of PIGK protein in primary tumors compared to paired normal tissues of colorectal cancer (CRC) patients. To understand the mechanism underlying this phenomenon, we performed sequencing of all 10 exons of the PIGK gene in 45 CRC patients. Corresponding PIGK protein expression was also evaluated in these patients by immunohistochemistry. No mutation was detected in the coding regions, however, we found a single nucleotide polymorphism (C/C→C/G or G/G; rs1048575) in the 3'UTR of the PIGK gene in 67% (30/45) of the patients. Most of the patients (22/26, 85%) with the altered alleles were of Jewish origin. In comparison, 47% (8/17) of the Arabian patients exhibited the altered C/G alleles. We observed a significantly low (p<0.002) expression of PIGK protein in the patients with the altered alleles

Regulatory mutations in the A2M gene are involved in the mastitis susceptibility in dairy cows

“…; Dasgupta et al . ). Mastitis is characterized by an influx of somatic cells into the mammary glands of dairy cattle, and SCC is a positive indicator of mastitis (Suske ).…”

Novel insights into the roles of migrasome in cancer

“…They hypothesized that the mutations in the coding region of the PIGK gene may lead to altered PIGK expression. In 2012, research demonstrated, for the first time, that SNP1048575 was related to low PIGK expression in CRC/ patients and a possible association between altered PIGK expression and disease susceptibility by direct sequencing and immunohistochemistry[ 106 ]. From what has been discussed above, for CRC/HCC/UCC, PIGK is a promising potential therapeutic target.…”

Migrasomes and Tetraspanins in Hepatocellular Carcinoma: Current Status and Future Prospects

“…EOGT is associated with immune infiltration and has the potential to differentiate prognostic markers in patients with hepatocellular carcinoma [ 51 ]. SNP 1048575 was associated with low expression of PIGK in patients with hepatocellular carcinoma [ 52 ]. These highly expressed genes may serve as genetic markers for hepatocellular carcinoma, suggesting a poor prognosis.…”